Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -4.46% | -15.08% | +94.55% |
05-14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.55% | 41.34M | |
+33.57% | 49.46B | |
+1.74% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.74% | 26.61B | |
-22.16% | 18.64B | |
+7.82% | 13.16B | |
+29.52% | 12.55B | |
+24.11% | 12.1B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- HC Wainwright Starts Xilio Therapeutics at Buy with $36 Price Target